Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain
- 1 December 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 126 (1), 102-114
- https://doi.org/10.1016/j.pain.2006.06.016
Abstract
Selective activation of the peripheral cannabinoid receptor 1 (CB1R) has been shown to suppress neuropathic pain symptoms in rodents. However, relatively little is known about changes in CB1R and its endogenous ligands during development or maintenance of neuropathic pain. Using immunohistochemistry, Western blot, real-time reverse transcription polymerase chain reaction, as well as liquid chromatography/mass spectrometry, we studied the changes in CB1Rs and endocannabinoids N-arachidonoylethanolamine/anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in rat lumbar (L4 and L5) dorsal root ganglia (DRG) after neuropathic pain induction (L5 spinal nerve ligation: SNL). Immunohistochemistry revealed that in control rats, CB1R is expressed in the majority (76–83%) of nociceptive neurons as indicated by co-labeling with isolectin B4 (IB4) or antibodies recognizing transient receptor potential vanilloid (TRPV1), calcitonin gene related peptide (CGRP), and the NR2C/2D subunits of the N-methyl- d-aspartate receptor. After L5 SNL, CB1R mRNA and protein increases in the ipsilateral uninjured L4 DRG whereas the percentages of CB1R immunoreactive (CB1R-ir) neurons remain unchanged in L4 and L5 DRG. However, for these CB1R-ir neurons, we observe significant increases in percentage of TRPV1-ir cells in ipsilateral L4 DRG, and decreases in percentage of IB4- and CGRP-co-labeled cells in ipsilateral L5 DRG. Levels of both AEA and 2-AG increase significantly only in the ipsilateral L5 DRG. These results are consistent with the preserved analgesic effects of cannabinoids in neuropathic pain and provide a rational framework for the development of peripherally acting endocannabinoid-based therapeutic interventions for neuropathic pain.Keywords
This publication has 85 references indexed in Scilit:
- Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic miceJournal of Neurochemistry, 2004
- Loss of Peripheral Morphine Analgesia Contributes to the Reduced Effectiveness of Systemic Morphine in Neuropathic PainThe Journal of pharmacology and experimental therapeutics, 2004
- Similar Electrophysiological Changes in Axotomized and Neighboring Intact Dorsal Root Ganglion NeuronsJournal of Neurophysiology, 2003
- Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexusJournal of Comparative Neurology, 2002
- Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overviewProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Cannabinoid CB1 Receptor Expression in Rat Spinal CordMolecular and Cellular Neuroscience, 2000
- ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Transacylase‐Mediated and Phosphodiesterase‐Mediated Synthesis of N‐Arachidonoylethanolamine, an Endogenous Cannabinoid‐Receptor Ligand, in Rat Brain MicrosomesJBIC Journal of Biological Inorganic Chemistry, 1996
- The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent driveNeuroscience Letters, 1995
- Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markersJournal of Neurocytology, 1990